课题基金 / 基金详情

Phosphoinositide Phosphatases

Phosphoinositide Phosphatases
磷酸肌醇磷酸酶
批准号:
8036713
负责人:
JACK E DIXON
金额:
$10.0万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-03-16 至 2011-02-28
关键词:
1,2-diacylglycerolAccountingActive SitesAddressAffectAffinityAmino Acid MotifsAmino AcidsAnimalsApoptosisAwarenessAxonBacteriaBindingBiochemicalBlast CellC-terminalCDC42 geneCatalysisCatalytic DomainCell CommunicationCell FractionationCell physiologyCellsCentronuclear myopathyCharacteristicsCharcot-Marie-Tooth DiseaseChargeCitric Acid CycleCleaved cellClinicalCo-ImmunoprecipitationsCoiled-Coil DomainComplexCoomassie blueCore ProteinDatabasesDemyelinationsDeuteriumDictyosteliumDiglyceridesDiseaseElectrostaticsEmbryoEnzymesEtiologyEubacteriumEukaryotaEventEvolutionExhibitsFaceFamilyFamily memberFive-Year PlansFluorescence MicroscopyGTP Phosphohydrolase ActivatorsGenesGeneticGenetically Engineered MouseGenomeGlucoseGlucosyltransferaseGlucosyltransferasesGoalsGrantGrowthGuanosine Triphosphate PhosphohydrolasesHeadHeterodimerizationHomology ModelingHumanHydrogen BondingIn VitroInborn Genetic DiseasesInitiator CodonInositolInstructionKeto AcidsKidneyKnockout MiceLaboratoriesLeadLengthLifeLightLinkLipid BindingLipidsLiverMALDI-TOF Mass SpectrometryMass Spectrum AnalysisMediatingMediator of activation proteinMembraneMembrane ProteinsMetabolismMichiganMissense MutationMitochondriaModelingMolecularMolecular ConformationMotorMusMutateMutationMyelinNatureNerveNeural ConductionNeurodegenerative DisordersNeuromuscular DiseasesNeuronsNeuropathyNon-Insulin-Dependent Diabetes MellitusOperonOrganellesOrganismOrthologous GeneOxidative PhosphorylationOxidoreductaseOxygenPH DomainPTEN genePancreasPathway interactionsPatientsPenetrationPeripheralPeripheral NervesPeripheral Nervous SystemPeripheral Nervous System DiseasesPhasePhenotypePhosphatidylinositolsPhospholipidsPhosphoproteinsPhosphoric Monoester HydrolasesPhosphorylationPhosphotransferasesPhylogenetic AnalysisPhysiologicalPlant ResinsPositioning AttributePostdoctoral FellowProductionProtein BindingProtein Binding DomainProtein DephosphorylationProtein FamilyProtein Tyrosine PhosphataseProtein phosphataseProteinsProteolysisPyruvatePyruvate Dehydrogenase ComplexPyruvatesRattusRecombinantsRegulationRelative (related person)ReportingRoentgen RaysRoleSchwann CellsSeriesSideSignal TransductionSignal Transduction PathwaySiteSkeletal MuscleSlideSolutionsSolventsSpecificitySplice-Site MutationStaining methodStainsStructureSubstrate SpecificitySuggestionSulfonylurea CompoundsSurfaceTechniquesTerminator CodonTestingTestisThinkingTimeTransgenic MiceUniversitiesWaterWorkafferent nervebasecareercell motilitycell typedihydrolipoamide dehydrogenaseearly onsetexpression vectorhuman diseasein vitro activityin vivoinorganic phosphateinsertion/deletion mutationinsightinsulin secretioninterestinterfacialmembermouse modelmutantmyotubularinnovelphosphatidylinositol 3,5-diphosphatephosphatidylinositol 3-phosphateplatelet protein P47preferenceprofessorprotein protein interactionprotein structureresponserhosciatic nervetherapeutic targettool

项目摘要

项目成果

JACK E DIXON的其他基金

相似基金

相关文献

中文摘要
翻译
蛋白质酪氨酸磷酸酶超家族,所有这些都包含一个高度保守的活性位点基序,Cys-
英文摘要
The protein tyrosine phosphatase superfamily, all of which contain a highly conserved active site motif, Cys- X5-Arg (CX5R) are key mediators of a wide variety of cellular processes, including growth, metabolism, differentiation, motility, and programmed cell death. Our laboratory has demonstrated that some phosphatases harboring CX5R motifs utilize phosphoinositides instead of phosphoproteins as their physiological substrates. This includes the myotubularin (MTM) subfamily that removes the 3-phosphate from phosphatidylinositol 3-phosphate (PI(3)P) and phosphatidylinositol 3,5-bisphosphate (PI(3,5)P2. Mutations in MTM family members have been shown to cause the human neuromuscular disorders myotubular myopathy and Charcot-Marie-Tooth disease (CMT). This proposal will continue to study the regulation of the MTM family of PTPs as well as another novel phosphatase known as PTPMT1. In the next five years, we plan to develop a better understanding of how levels of PI(3)P transmit signals in the cell. First, we will explore the roles of MTMR2 and MTMR13 with respect to a new protein known as Frabin.which senses changes in PI(3)P levels resulting in the modulation of the activity of CDC42 and other Rho-like GTPases. Specifically, we will examine Frabin's role in mediating PI(3)P signal transduction events in Schwann cells, cells that produce myelin for insulating axons. We will then determine if this signal transduction pathway is widely used in other cell types. Second, we have demonstrated that PTPMT1 regulates insulin secretion by decreasing ATP production in INS-1 cells. In order to address PTPMTI's mechanism of action, we genetically engineered mice in which the PTPMT1 gene has been ablated. We are characterizing these mice phenotypically and will combine a series of systemic and biochemical approaches to study the role of PTPMT1 in cellular and whole animal contexts.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Lafora epilepsy mechanisms: insights into brain metabolism
CHARACTERIZE THE FUNCTION OF PROTEIN TYROSINE PHOSPHATASE PTPMT1 IN MITOCHONDRIA
ASSIGNMENT OF POSTTRANSLATIONAL MODIFICATIONS IN STREPTOLYSIN-S ANALOGUE
  • 批准号:
    8168991
  • 项目类别:
  • 资助金额:
    $0.19万
  • 财政年份:
    2010
  • 负责人:
    JACK E DIXON
  • 依托单位:
YopT: A Yersinia Virulence Factor
海外基金